Top News

Road sign displaying the words Fast Track against a blue sky

RESEARCH

16 Jan 2026

FDA Fast Tracks Dual-Action MASH Drug: Is Momentum Back?

FDA grants two expedited reviews to a dual-action MASH drug, reviving interest in metabolic approaches without signaling a policy overhaul

Close-up of GLP-1 text under magnifying glass with obesity and diabetes terms

MARKET TRENDS

5 Feb 2026

Patients Take the Lead in US Metabolic Drug Pricing

PARTNERSHIPS

3 Feb 2026

AstraZeneca Brings AI In-House to Speed Drug Discovery

Latest News

INNOVATION
8 Apr 2026
A Weight-Loss Pill Without the Strings Attached
PARTNERSHIPS
7 Apr 2026
Insilico Does the Math, Lilly Writes the Check
INVESTMENT
6 Apr 2026
Meet the Startup Trying to Out-Ozempic Ozempic
PARTNERSHIPS
31 Mar 2026
The Shot Is So Last Year. Lilly Wants You to Pop a Pill

Wegovy Turns Up the Dial and Takes Aim at Lilly

Wegovy FlexTouch injection pens labeled 0.25 mg and 1 mg doses

REGULATORY

26 Mar 2026

The FDA approved Novo Nordisk's 7.2 mg Wegovy HD in 54 days, with trial data showing 20.7% average weight loss

RESEARCH

21 Jun 2025

Stem Cell Trial Offers Hope for Insulin-Free Diabetes

Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles

10 11

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.